EGFR is also overexpressed in this subgroup of breast cancers[11], and in-vitro data suggest that crosstalk between α6β4 integrin and EGFR may be important in the progression of this basal subtype of breast cancers [12-14]. The gene discussed is EGFR; the disease is breast carcinoma.